Research reveals links between dietary fatty acids and kidney stone risk, highlighting the need for targeted dietary strategies to mitigate this health issue.
Findings reveal fluoxetine’s weak antiviral effects in COVID-19, with no significant benefits in symptom resolution compared to other antiviral treatments.
Advances in technology have made it increasingly easier for people to self-monitor their heart health whether it’s via a smart device on their wrist or
While advances in diabetes care have improved survival rates, this study highlights persistent ethnic disparities in mortality risk, urging tailored healthcare strategies to address diverse
Gut microbiota plays a critical role in childhood obesity by influencing energy metabolism, inflammation, and appetite regulation, with emerging therapeutic strategies like probiotics, dietary interventions,
Skeletal muscle fat infiltration (IMAT) is linked to coronary microvascular dysfunction and increased cardiovascular risk, independent of BMI and traditional risk factors.
Research explores the profound impact of climate change on neurological health, focusing on how rising temperatures, extreme weather, and air pollution exacerbate conditions like epilepsy,
The Trump administration’s decision to withdraw from the World Health Organization could complicate US access to health information that’s vital for pharmaceutical companies, academics said
Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS
Johnson & Johnson’s Spravato nasal spray received a label expansion on Tuesday, now approved as a standalone treatment for major depressive disorder in adults after